Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study-Reference-Cited by-同舟云学术

Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study

Published:2021-06-14 Issue:9 Volume:394 Page:1949-1961
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Pateliya Bharat^ORCID,Burade Vinod,Goswami Sunita

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00210-021-02104-3.pdf

Reference39 articles.

1. Ajzashokouhi AH, Bostan HB, Jomezadeh V et al (2020) A review on the cardioprotective mechanisms of metformin against doxorubicin. Hum Exp Toxicol 39:237–248. https://doi.org/10.1177/0960327119888277

2. Aljofan M, Riethmacher D (2019) Anticancer activity of metformin: a systematic review of the literature. Futur Sci OA 5. https://doi.org/10.2144/fsoa-2019-0053

3. Alyahya R, Sudha T, Racz M et al (2015) Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. Int J Oncol 46:1225–1231. https://doi.org/10.3892/ijo.2014.2803

4. Bissery MC, Gueritte-Voegelein F (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a Taxol Analogue. Cancer Res 51:4845–4852

5. Burade V, Bhowmick S, Maiti K et al (2017) Lipodox® (generic doxorubicin hydrochloride liposome injection): In vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse mode. BMC Cancer 17:1–12. https://doi.org/10.1186/s12885-017-3377-3

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicological effects of dimethlybenzeneanthracene in Balb C mice and pharmacological intervention by silk sericin–conjugated silver nanoparticles;Science Progress;2024-01

2. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024

3. Metformin pretreatment potentiates the antiproliferative action of doxorubicin against breast cancer;Annales Pharmaceutiques Françaises;2023-06

4. Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer;Antioxidants;2023-02-27

5. Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis;International Journal of Molecular Sciences;2022-12-25